“We are pleased that the
The resale registration statement, while effective, allows selling stockholders to publicly resell their shares of Ignyta common stock, subject to the satisfaction by selling stockholders of the prospectus delivery requirements of the Securities Act of 1933, as amended, in connection with any such resale. The company will not receive any proceeds from any sales by selling stockholders, and the company is not aware of any plans by selling stockholders to effect such resales.
The offering of these securities may only be made by means of a prospectus. A registration statement relating to these securities has been declared effective by the
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the company’s securities, nor shall there be any sale of these securities in any state in which offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
This press release contains forward-looking statements as that term is defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, references to the potential for a liquid trading market for our common stock to develop; our novel technologies and methods; our progress in developing new oncology therapies; our business and product development plans; and market information. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, our ability to raise the additional funding we will need to continue to pursue our business and product development plans; the inherent uncertainties associated with developing new products or technologies and operating as a development stage company; our ability to develop, complete clinical trials for, obtain approvals for and commercialize any of our product candidates; competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this press release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents we file with the
CFO and Vice President, Corporate Development
Most Popular Stories
- Ukraine Crisis Limits Losses in Gold, Silver
- Can GOP Dodge Immigration Bullet?
- Software Writers Sought in Indiana
- Photo ID Required for Unemployment Benefits
- Chiquita, Fyffes to Form Top Banana
- Job Fair for S.C. Grads
- Tech Firms to Increase Hiring for 4th Year in a Row
- Big Earthquake Rumbles Northern California
- China's Money Rate Drops on Slowdown Concern
- '300' Sequel Conquers Box Office Foes